KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Net Margin (2018 - 2025)

BioNTech SE's Net Margin history spans 8 years, with the latest figure at 822.1% for Q4 2025.

  • On a quarterly basis, Net Margin fell 82211.0% to 822.1% in Q4 2025 year-over-year; TTM through Dec 2025 was 70.19%, a 7017.0% decrease, with the full-year FY2025 number at 39.59%, up 61145.0% from a year prior.
  • Net Margin hit 822.1% in Q4 2025 for BioNTech SE, down from 1.89% in the prior quarter.
  • Over the last five years, Net Margin for BNTX hit a ceiling of 196.54% in Q3 2024 and a floor of 5369.23% in Q2 2025.
  • Historically, Net Margin has averaged 409.07% across 5 years, with a median of 24.55% in 2021.
  • Biggest five-year swings in Net Margin: surged 16368bps in 2024 and later plummeted -474157bps in 2025.
  • Tracing BNTX's Net Margin over 5 years: stood at 0.0% in 2021, then surged by 166085745bps to 95.05% in 2022, then tumbled by -67bps to 30.96% in 2023, then crashed by -100bps to 0.01% in 2024, then tumbled by -10454582bps to 822.1% in 2025.
  • Business Quant data shows Net Margin for BNTX at 822.1% in Q4 2025, 1.89% in Q3 2025, and 5369.23% in Q2 2025.